文献速递脑血管病神经重症与神经感染

脑出血后降压治疗与结局的性别差异:ATACH-2 结果

Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2.
PubMed 文献 · Stroke · 2020-07-06

基于 ATACH-2 试验数据,纳入 380 名女性和 620 名男性脑出血患者,分析性别与强化降压治疗效果的交互作用。女性死亡或残疾相对风险为 1.19(95%CI 1.02-1.37,P=0.023),强化降压获益在女性中不确定,与总体结果一致。

要点

  • 女性脑出血后死亡或残疾风险高于男性(RR 1.19)。
  • 女性接受强化降压治疗的获益不确定。
  • 性别与治疗交互作用无统计学意义(P=0.11)。

核心结论

  • 女性脑出血后死亡或残疾风险更高,强化降压治疗在女性中的获益不确定,与 ATACH-2 总体结果一致。

研究设计与样本

  • ATACH-2 随机对照试验的事后分析,纳入 380 名女性和 620 名男性脑出血患者,随机接受强化降压(收缩压目标 110-139 mm Hg)或标准降压(140-179 mm Hg)治疗,发病 4.5 小时内开始。

主要发现

  • 女性年龄更大、发病前使用降压药更多、脑叶出血更多,血肿扩大较少。
  • 多变量调整后,女性死亡或残疾相对风险为 1.19(95%CI 1.02-1.37,P=0.023)。
  • 强化 vs 标准降压的死亡或残疾相对风险在女性为 0.91(95%CI 0.74-1.13),男性为 1.13(95%CI 0.92-1.39),交互作用 P=0.11。
  • Gail-Simmon 检验 P=0.16,结果不确定。

关键数值与推荐

  • 强化降压目标收缩压 110-139 mm Hg,标准降压目标 140-179 mm Hg。
  • 主要结局为死亡或残疾(改良 Rankin 量表评分 4-6)。

临床怎么用

  • 临床需关注女性脑出血患者死亡或残疾风险较高,强化降压在女性中的获益尚不确定。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Evidence regarding sex differences in clinical outcomes and treatment effect following intracerebral hemorrhage is limited. Using the ATACH-2 trial (Antihypertensive Treatment in Intracerebral Hemorrhage-2) data, we explored whether sex disparities exist in outcomes and response to intensive blood pressure (BP)-lowering therapy. METHODS: Eligible intracerebral hemorrhage subjects were randomly assigned to intensive (target systolic BP, 110-139 mm Hg) or standard (140-179 mm Hg) BP-lowering therapy within 4.5 hours after onset. Relative risk of death or disability corresponding to the modified Rankin Scale score of 4 to 6 was calculated, and interaction between sex and treatment was explored. RESULTS: In total, 380 women and 620 men were included. Women were older, more prescribed antihypertensive drugs before onset, and had more lobar intracerebral hemorrhage than men. Hematoma expansion was observed less in women. After multivariable adjustment, the relative risk of death or disability in women was 1.19 (95% CI, 1.02-1.37, P=0.023). The relative risk of death or disability between intensive versus standard BP-lowering therapy was 0.91 (95% CI, 0.74-1.13) in women versus 1.13 (95% CI, 0.92-1.39) in men (P for interaction=0.11), with inconclusive Gail-Simmon test (P=0.16). CONCLUSIONS: Women had a higher risk of death or disability following intracerebral hemorrhage. The benefit of intensive BP-lowering therapy in women is inconclusive, consistent with the overall results of ATACH-2. Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01176565.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Fukuda-Doi M, Yamamoto H, Koga M, et al. Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2. Stroke. 2020. PMID: 32623977. doi:10.1161/STROKEAHA.120.029770

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。